New insights into the P-glycoprotein-mediated effluxes of rhodamines

European Journal of Biochemistry

Volumn 270, Issue 3, 2003, Pages 476-485

  Loetchutinat, Chatchanok ^a   Saengkhae, Chantarawan ^a   Marbeuf Gueye, Carole ^a   Garnier Suillerot, Arlette ^a  

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

Efflux; Membrane transport; Multidrug resistance; P glycoprotein; Rhodamine

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC ANTIBIOTIC; CARBONYL CYANIDE 4 (TRIFLUOROMETHOXY)PHENYLHYDRAZONE; DAUNORUBICIN; GLYCOPROTEIN P; IDARUBICIN; IONOPHORE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PIRARUBICIN; RHODAMINE; RHODAMINE 123; RHODAMINE 6G; RHODAMINE B; VALINOMYCIN; VERAPAMIL;

ARTICLE; BINDING AFFINITY; BINDING KINETICS; CELL STRAIN K 562; CONTROLLED STUDY; DRUG TRANSPORT; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; ISOTOPE LABELING; LEUKEMIA CELL; MATHEMATICAL ANALYSIS; MEMBRANE PERMEABILITY; MEMBRANE TRANSPORT; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; FLUORESCENT DYES; HUMANS; K562 CELLS; P-GLYCOPROTEIN; RHODAMINES;

EID: 0037317830     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1033.2003.03403.x     Document Type: Article

References (34)

1. Bradley, G., Juranka, P.F. & Ling, V. (1988) Mechanism of multidrug resistance. Biochim. Biophys. Acta 848, 87-128.
2. Gottesman, M.M. & Pastan, I. (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62, 385-427.
3. Borst, P. & Ouellette, M. (1995) New mechanisms of drug resistance in parasitic protozoa. Annu. Rev. Microbiol. 49, 427-460.
4. Van Veen, H.W. & Konings, W.N. (1998) The ABC family of multidrug transporters in microorganisms. Biochim. Biophys. Acta 1365, 31-36.
5. Altenberg, G.A., Vanoye, C.G., Horton, J.K. & Reuss, L. (1994) Unidirectionalfluxes of rhodamine 123 in multidrug-resistant cells: evidence againts direct extrusion from the plasma mambrane. Proc. Natl Acad. Sci. USA 91, 4654-4657.
6. Sharom, F.J. (1997) The P-glycoprotein efflux pump: how does it transport drugs? J. Membr. Biol. 160, 161-175.
7. Eytan, G.D., Regev, R., Oren, G., Hurwitz, C.D. & Assaraf, Y.G. (1997) Efficiency of P-glycoprotein-mediated exclusion of rhodamine dues from multidrug-resistant cells is determined by their passive transmembrane movement rate. Eur. J. Biochem. 248, 104-112.
8. Garnier-Suillerot, A., Marbeuf-Gueye, C., Salernoa, M., Loetchutinat, C., Fokt, I., Krawczyk, M., Kowalczyk, T. & Priebe, W. (2001) Analysis of drug transport kinetics in multidrug-resistant cells: implications for drug action. Curr. Med. Chem. 8, 51-64.
9. Vergote, J., Moretti, J.-L., DeVries, E.G.E. & Garnier-Suillerot, A. (1998) Comparison of the kinetics of active efflux of Tc-99m-MIBI in cells with P-glycoprotein-mediated and multidrug-resistance protein-associated multidrug-resistance phenotypes. Eur. J. Biochem. 252, 140-146.
10. Marbeuf-Gueye, C., Broxterman, H., Dubru, F., Priebe, W. & Garnier-Suillerot, A. (1998) Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells. Mol. Pharmacol. 53, 141-147.
11. Frézard, F., Pereira-Maia, E., Quidu, P., Priebe, W. & Garnier-Suillerot, A. (2001) P-glycoprotein preferentially effluxes anthracyclines containing free basic versus charged amine. Eur. J. Biochem. 268, 1561-1567.
12. Loetchutinat, C., Heywang, C., Priebe, W. & Garnier-Suillerot, A. (2001) The absence of stereoselective P-glycoprotein- and multidrug resistance-associated protein-mediated transport of daunorubicin. Biochem. Pharmacol. 62, 561-567.
13. Salerno, M., Przewloka, T., Fokt, I., Priebe, W. & Garnier-Suillerot, A. (2002) Preferential efflux by P-glycoprotein, but not MRP1, of compounds containing a free electron donor amine. Biochem. Pharmacol. 63, 1471-1479.
14. Lu, P., Liu, R. & Sharom, F.J. (2001) Drug transport by reconstituted P-glycoprotein in proteoliposomes - Effect of substrates and modulators, and dependence on bilayer phase state. Eur. J. Biochem. 268, 1687-1695.
15. Lozzio, C.B. & Lozzio, B.B. (1975) Human chronic myelogeneous leukemia cell line positive Philadelphia chromosome. Blood 45, 321-334.
16. Tsuruo, T., Iida, H., Kawataba, H., Oh-Hara, T., Hamada, H. & Utakoji, T. (1986) Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones. Jpn. J. Cancer Res. 77, 682-687.
17. Maniatis, T., Fristch, E. & Sambrook, J. (1982) Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory Press, New York.
18. Ferrandis, E., Da Silva, J., Riou, J. & Benard, J. (1994) Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse. Cancer Res. 54, 2256-2261.
19. Golstein, L.J., Fojo, A.T., Crist, W., Green, A., Brodeur, G., Pastan, I. & Gottesman, M.M. (1990) Expression of the multidrug resistance, MDR1, gene in neuroblatomas. J. Clin. Oncol. 8, 128-136.
20. Williams, J.A. (1970) Origin of transmembrane potentials in non-excitable cells. J. Theor. Biol. 28, 287-296.
21. + homeostasis induced by the protonophore carbonyl cyanide-p-trifluoromethoxyphenyl-hydrazone in isolated nerve terminals. Mol. Pharmacol. 53, 734-741.
22. Borrel, M.N., Pereira, E., Fiallo, E. & Garnier-Suillerot, A. (1994) Mobile ionophores are a novel class of P-glycoprotein inhibitors - the effects of ionophores on 4′-O-tetrahydropyranyl-adriamycin incorporation in K562 drug-resistant cells. Eur. J. Biochem. 223, 125-133.
23. Goda, K., Krasznai, Z., Gaspar, R., Lankelma, J., Westerhoff, H., Damjanovich, S. & Szabo, G. (1996) Reversal of multidrug resistance by valinomycin is overcome by CCCP. Biochem. Biophys. Res. Comm. 219, 306-310.
24. + transport across phospholipids vesicular membrane by the combined action of carbonyl cyanide m-chlorophenylhydrazone and valinomycin: temperature-jump studies. Biochim. Biophys. Acta 235, 323-335.
25. Piwnica-Worms, D., Jacob, R., Horres, C.R. & Lieberman, M. (1983) Transmembrane chloride flux in tissue-cultured chick heart cells. J. Gen. Physiol. 81, 731-748.
26. Kachel, H., Fellner-Feldegg, H. & Menke, E. (1990) Hydrodynamic properties of flow cytometry instruments. In Flow Cytometry and Sorting (Melamed, M., Lindma, T. & Mendelsohn, eds), pp. 27-44. John Wiley & Sons, New York.
27. Kimmich, G., Randles, J. & Brand, J. (1975) Assay of picomole amounts of ATP, ADP and AMP using the luciferase enzymz system. Anal. Biochem. 69, 187-119.
28. Marbeuf-Gueye, C., Salerno, M., Quidu, P. & Garnier-Suillerot, A. (2000) Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P. Eur. J. Pharmacol. 391, 207-216.
29. Broxterman, H.J., Lankelma, J., Pinedo, H.M., Eekman, C.A., Wahrer, D.C.R., Ossenkoppele, G.J. & Schuurhuis, G.J. (1997) Theoretical and practical considerations for the measurement of P-glycoprotein function in acute myeloid leukemia. Leukemia 11, 1110-1118.
30. Petriz, J. & GarciaLopez, J. (1997) Flow cytometric analysis of P-glycoprotein function using rhodamine 123. Leukemia 11, 1124-1130.
31. Huet, S., Marie, J.P., Gualde, N. & Robert, J. (1998) Reference method for detection of Pgp mediated multidrug resistance in human hematological malignancies: a method validated by the laboratories of the French Drug Resistance Network. Cytometry 34, 248-256.
32. Marbeuf-Gueye, C., Ettori, D., Priebe, W., Kozlowski, H. & Garnier-Suillerot, A. (1999) Correlation between the kinetics of anthracycline uptake and the resistance factor in cancer ceils expressing the multidrug resistance protein or the P-glycoprotein. Biochim. Biophys. Acta 1450, 374-384.
33. Kessel, D., Beck, W.T., Kukuruga, D. & Schulz, V. (1991) Characterization of multidrug resistance by fluorescent dyes. Cancer Res. 51, 4665-4670.
34. Mankhetkorn, S., Dubru, F., Hesschenbrouck, J., Fiallo, M. & Garnier-Suillerot, A. (1996) Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells. Mol. Pharmacol. 49, 532-539.